• Home

  • Cannabis

  • Resource

  • Health/Biotech

  • Tech/Special Sits

  • All Client News

  • Contact

  • More

    Use tab to navigate through the menu items.
    • Home

    • Cannabis

    • Resource

    • Health/Biotech

    • Tech/Special Sits

    • All Client News

    • Contact

    • More...

      Use tab to navigate through the menu items.
      FRONTIER-MCG.jpg
      • Feb 17
      • 4 min
      Health | Biotechnology

      Resverlogix Expands Phase 2b Clinical Trial for COVID-19 with 1st Site in Brazil and 2nd in Canada

      A further five sites in Brazil and a third Canadian site, in Toronto, Ontario, will also be coming on line soon.

      • Apr 20, 2021
      • 3 min

      Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines

      Previously Announced Findings to Appear in the High-Impact Scientific Journal

      • Apr 12, 2021
      • 1 min
      Health | Biotechnology

      InvestmentPitch Media - New Listing: Rakovina Therapeutics Inc. (TSXV:RKV)

      • Mar 17, 2021
      • 3 min
      Health | Biotechnology

      Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell

      This collaborative research effort, employing state-of-the-art methods, has demonstrated apabetalone’s potential...

      • Mar 16, 2021
      • 1 min
      Media

      CTV News Calgary: Resverlogix Announces COVID-19 Trial

      • Jan 22, 2021
      • 3 min
      Health | Biotechnology

      Revive Therapeutics Included in First Psychedelic Exchange Traded Fund

      The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26 under the ticker PSYK on the NEO Exchange

      • Jan 14, 2021
      • 4 min
      Health | Biotechnology

      Revive Announces Research Collaboration with North Carolina State University for....

      The biosynthetic platform provides a potential simple and efficient method for rapidly producing natural

      • Dec 23, 2020
      • 7 min
      Health | Biotechnology

      Revive Update on Phase 3, COVID19 Clinical Trial with Bucillamine - Plans on Emergency Use Access..

      The Company’s clinical safety team has actively monitored ongoing interim data of patients and found there have been no safety concerns.....

      • Dec 21, 2020
      • 4 min
      Health | Biotechnology

      Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program

      The final terms will be agreed to by the parties after the completion of due diligence by Revive - Expected to close on or before Jan.31.21

      • Oct 20, 2020
      • 5 min

      Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

      Revive to source naturally-derived psychedelic compounds, such as psilocybin for use in future investigational new drug

      1
      2345

      Toronto | Montreal | Calgary | Vancouver

      ​

      https://www.frontiermcg.com

      About Us